The Impact of Artificial Intelligence on Corporate ESG Performance: The Mediation of R&D Intensity
Yulou Qiu(China Jiliang University), Lu Qian(Xi’an Jiaotong-Liverpool University), Hairong Lyu(University of Bristol), Yabin Yu(China Jiliang University)
Cited by 0
Related Papers
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
|Cell Death and Disease|2013|129
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome
|Cancer Science|2021|73
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy
|Annals of Hematology|2024|32
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease
|Cancer Immunology Immunotherapy|2021|22